Lize Merwe results 10
· Newest (Page 1/1, per page 25)
Author: Lize Merwe ×Clear All Filters
Search Results
CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical applicationNARA Subscribed
Approximately 25 % of clinically important drugs and numerous environmental carcinogens are metabolised by CYP2D6. Variation in the CYP2D6 gene and concomitant use of tamoxifen (TAM) with certain antidepressants may increase recurrence risk in breast cancer patients due to reduced enzyme activity. In this study we determined the appropriateness of adding CYP2D6 genotyping to the breast cancer genetic testing options already av...
Previous1Next